Profile data is unavailable for this security.
About the company
Jiangsu Lianhuan Pharmaceutical Co Ltd is a China-based company mainly engaged in pharmaceutical manufacturing and pharmaceutical distribution. The Company produces active pharmaceutical ingredients (APIs), tablets, injections and medical devices. The Company's main products include urinary system drugs, antihistamines, cardiovascular drugs, steroid hormones, antibiotics and others, covering chemical APIs and injections, solid preparations and other drug dosage forms, including products such as Aprelet Tablets (Chuanliu), Ebastine Tablets (Sudi) and Felodipine Tablets (Lianhuanerding). The Company mainly conducts its businesses in the domestic and foreign markets.
- Revenue in CNY (TTM)2.60bn
- Net income in CNY-43.60m
- Incorporated2000
- Employees1.39k
- LocationJiangsu Lianhuan Pharmaceutical Co LtdNo. 9 Health Road, YangzhouBiological Health Industrial ParkYANGZHOU 225127ChinaCHN
- Phone+86 51 487813082
- Fax+86 51 487815079
- Websitehttp://www.lhpharma.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Jibeier Pharmaceutical Co Ltd | 957.76m | 241.67m | 5.75bn | 1.33k | 23.85 | 2.44 | -- | 6.00 | 1.21 | 1.21 | 4.79 | 11.82 | 0.3733 | 3.26 | 3.71 | 721,747.90 | 9.37 | 8.99 | 10.04 | 9.78 | 87.92 | 88.72 | 25.11 | 23.97 | 7.17 | -- | 0.0092 | 32.97 | 4.14 | 10.57 | 0.1095 | 14.20 | 42.01 | -- |
| Jiangsu Lianhuan Pharmaceutical Co. Ltd | 2.60bn | -43.60m | 6.02bn | 1.39k | -- | 4.51 | -- | 2.32 | -0.1527 | -0.1527 | 9.10 | 4.68 | 0.7279 | 3.28 | 4.16 | 1,872,001.00 | -0.8081 | 5.51 | -1.74 | 10.75 | 36.36 | 51.36 | -1.11 | 7.34 | 0.7909 | 1.88 | 0.4592 | 30.61 | -0.6275 | 10.86 | -37.66 | 1.09 | 1.85 | 1.16 |
| ChengDu Sheng Nuo Biotec Co Ltd | 638.35m | 120.09m | 6.15bn | 1.38k | 51.33 | 5.96 | -- | 9.64 | 0.7615 | 0.7615 | 4.09 | 6.56 | 0.3714 | 0.973 | 4.28 | 462,238.30 | 6.98 | 6.05 | 10.10 | 7.75 | 55.34 | 66.00 | 18.80 | 14.91 | 0.9008 | 14.11 | 0.3862 | 26.83 | 4.84 | 6.90 | -28.88 | 0.7741 | 51.66 | -- |
| Hunan Warrant Pharmaceutical Co Ltd | 1.43bn | 213.03m | 6.17bn | 1.24k | 28.94 | 3.09 | -- | 4.31 | 1.62 | 1.62 | 10.89 | 15.17 | 0.554 | 1.40 | 7.99 | 1,154,661.00 | 7.61 | 9.47 | 8.79 | 11.61 | 59.10 | 67.03 | 13.74 | 13.01 | 3.03 | -- | 0.1503 | 14.11 | -1.38 | 11.37 | -22.24 | 7.21 | 57.23 | -- |
| Kexing Biopharm Co Ltd | 1.52bn | 125.57m | 6.26bn | 947.00 | 49.49 | 3.60 | -- | 4.13 | 0.6288 | 0.6288 | 7.47 | 8.65 | 0.473 | 4.20 | 2.90 | 1,601,171.00 | 3.82 | -0.1893 | 5.31 | -0.2413 | 63.12 | 74.57 | 8.07 | -0.3956 | 1.38 | 63.54 | 0.4489 | -- | 11.75 | 3.39 | 116.54 | -27.74 | 11.90 | -- |
Data as of Feb 11 2026. Currency figures normalised to Jiangsu Lianhuan Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
0.12%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Baoying Fund Management Co., Ltd.as of 30 Jun 2025 | 142.10k | 0.05% |
| Huatai-PineBridge Fund Management Co., Ltd.as of 30 Jun 2025 | 125.50k | 0.04% |
| Everbright PGIM Fund Management Co. Ltd.as of 30 Jun 2025 | 32.70k | 0.01% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2025 | 17.70k | 0.01% |
| Western Leadbank Fund Management Co., Ltdas of 30 Jun 2025 | 7.40k | 0.00% |
| Fullgoal Fund Management Co., Ltd.as of 30 Jun 2025 | 5.80k | 0.00% |
| Orient Fund Management Co., Ltd.as of 30 Jun 2025 | 4.20k | 0.00% |
| Cinda Securities Co., Ltd. (Investment Management)as of 30 Jun 2025 | 3.30k | 0.00% |
| Wanjia Asset Management Co., Ltd.as of 30 Jun 2025 | 2.80k | 0.00% |
| Cinda Fund Management Co. Ltd.as of 30 Jun 2025 | 2.40k | 0.00% |
More ▼
Data from 30 Jun 2025 - 30 Jun 2025Source: FactSet Research Systems Inc.
